Open AccessRetracted: Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
Author(s) -
Fengli Zhang,
Huixiao Chen,
Jing Du,
Bin Wang,
Lixiao Yang
Publication year - 2021
Publication title -
medical science monitor
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.636
H-Index - 85
eISSN - 1643-3750
pISSN - 1234-1010
DOI - 10.12659/msm.932331
Subject(s) - metformin , pi3k/akt/mtor pathway , protein kinase b , cyr61 , cancer research , anticancer drug , drug , ovarian cancer , pharmacology , signal transduction , chemistry , cancer , medicine , biology , microbiology and biotechnology , diabetes mellitus , endocrinology , receptor , growth factor , ctgf
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom